Autologous Mesenchymal Stem Cell Therapy (Hadassah Medical Organization)

N/A

Report date: 2025/12/31 20:01:55

Base Information

Drug NameAutologous Mesenchymal Stem Cell Therapy (Hadassah Medical Organization)

Drug Alias NameMesenchymal stem cellsMSC

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHadassah Medical Organization

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHadassah Medical Organization

Active IndicationsN/A

Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A